Star Equity Fund Issues Statement on Inaction of Servotronics Board Entrenched SVT Board Dismisses Star Equity’s Proposal in Neglect of its Fiduciary DutyIncumbents Not Focused on Maximizing Shareholder Value OLD GREENWICH, Conn., Nov. 14, 2022 (GLOBE...

Star Equity Fund Issues Statement on the Results of Servotronics 2022 AGM Election Results Confirm Significant Shareholder Frustration Calls on Ed Cosgrove and Lucion Gygax to Resign OLD GREENWICH, Conn., June 23, 2022 (GLOBE NEWSWIRE) -- Star Equity Fund, LP (“Star...

Star Equity Fund Encourages Servotronics Shareholders to Vote WITHHOLD on the Re-Election of Ed Cosgrove and Lucion Gygax OLD GREENWICH, Conn., May 24, 2022 (GLOBE NEWSWIRE) -- Star Equity Fund, LP (“Star Equity Fund”, “we”, “our”), a shareholder of Servotronics, Inc. (NYSE American: SVT) (“Servotronics” or “the...

Star Equity Fund Issues Statement on Successful Campaign at Servotronics Was Change Agent for Recent Board ChangesWill Continue to Monitor Company’s Progress and Act if Needed OLD GREENWICH, Conn., May 13, 2022 (GLOBE NEWSWIRE) -- Star Equity Fund, LP (“Star Equity...

Specimen Validity Testing (SVT) Market Is Expected To Witness Faster Growth During The Forecast Period 2021-2030 In Asia Pacific - Report By Acumen Research And Consulting LOS ANGELES, April 22, 2021 (GLOBE NEWSWIRE) -- Specimen validity testing (SVT) is performed on a urine drug screen specimen to measure the pH, and specific gravity, ensuring that no adulterant has...